将血细胞和蛋白质工程化为血液替代品：简要综述。
Engineering blood cells and proteins as blood substitutes: A short review.
作者信息
Kim Hae Won
机构信息
1Brown University Medical School and The Miriam Hospital, 164 Summit Avenue, 02906 Providence, Rhode Island USA.
出版信息
Biotechnol Bioprocess Eng. 2007;12(1):43. doi: 10.1007/BF02931802.
Abstract
In this brief review, basic principles and recent progresses on the development of therapeutic substitutes for major blood components are briefly discussed with primary focus on the red cell substitutes.
摘要
在这篇简短的综述中，我们简要讨论了主要血液成分治疗替代物开发的基本原理和最新进展，重点是红细胞替代物。
相似文献
1
Engineering blood cells and proteins as blood substitutes: A short review.将血细胞和蛋白质工程化为血液替代品：简要综述。
Biotechnol Bioprocess Eng. 2007;12(1):43. doi: 10.1007/BF02931802.
2
Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.迈向21世纪的血液成分替代疗法：人工氧载体、血小板替代品、重组凝血因子及其他。
Artif Cells Blood Substit Immobil Biotechnol. 2006;34(6):537-50. doi: 10.1080/10731190600973725.
3
Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.以基于血红蛋白的红细胞血液替代品的纳米生物技术为例探讨人工细胞的发展。
Artif Cells Blood Substit Immobil Biotechnol. 2006;34(6):551-66. doi: 10.1080/10731190600973808.
4
Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.作为红细胞替代物的人工氧载体：一篇精选综述及现状
Artif Organs. 2004 Sep;28(9):813-28. doi: 10.1111/j.1525-1594.2004.07345.x.
5
Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility.人工血液替代品：通往临床应用漫长道路上的第一步。
Clin Med Insights Blood Disord. 2016 Oct 27;9:33-41. doi: 10.4137/CMBD.S38461. eCollection 2016.
6
[Artificial blood].[人造血液]
Nihon Geka Gakkai Zasshi. 2005 Jan;106(1):31-7.
7
[Current status of researches in the development of blood tissue engineering product].[血液组织工程产品研发的研究现状]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Aug;25(4):972-5.
8
Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes.基于微粒、纳料和干细胞的氧载体作为先进的血液代用品。
Trends Biotechnol. 2014 Sep;32(9):466-73. doi: 10.1016/j.tibtech.2014.05.001. Epub 2014 Jun 12.
9
Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.血红蛋白囊泡作为红细胞替代品的药代动力学特性。
Drug Metab Rev. 2011 Aug;43(3):362-73. doi: 10.3109/03602532.2011.558094. Epub 2011 Mar 23.
10
Review of hemoglobin-vesicles as artificial oxygen carriers.血红蛋白囊泡作为人工氧载体的综述。
Artif Organs. 2009 Feb;33(2):139-45. doi: 10.1111/j.1525-1594.2008.00698.x.
引用本文的文献
1
Sex differences in the blood-brain barrier and neurodegenerative diseases.血脑屏障与神经退行性疾病中的性别差异。
APL Bioeng. 2021 Mar 16;5(1):011509. doi: 10.1063/5.0035610. eCollection 2021 Mar.
2
Mannosylated Cationic Copolymers for Gene Delivery to Macrophages.甘露糖修饰的阳离子共聚物用于向巨噬细胞传递基因。
Macromol Biosci. 2021 Apr;21(4):e2000371. doi: 10.1002/mabi.202000371. Epub 2021 Feb 22.
本文引用的文献
1
Engineering high affinity superantigens by phage display.通过噬菌体展示技术构建高亲和力超抗原
J Mol Biol. 2005 Mar 18;347(1):107-20. doi: 10.1016/j.jmb.2005.01.020. Epub 2005 Jan 25.
2
Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.作为红细胞替代物的人工氧载体：一篇精选综述及现状
Artif Organs. 2004 Sep;28(9):813-28. doi: 10.1111/j.1525-1594.2004.07345.x.
3
Recombinant biologics for treatment of bleeding disorders.用于治疗出血性疾病的重组生物制品。
Nat Rev Drug Discov. 2004 Aug;3(8):684-94. doi: 10.1038/nrd1443.
4
Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery.使用一种氧疗方法作为术中自体输血的辅助手段，以减少冠状动脉搭桥手术患者的输血需求。
J Am Coll Surg. 2004 Mar;198(3):373-83; discussion 384-5. doi: 10.1016/j.jamcollsurg.2003.11.020.
5
Hemostatic effects of polymerized albumin particles bearing rGPIa/IIa in thrombocytopenic mice.携带rGPIa/IIa的聚合白蛋白颗粒在血小板减少小鼠中的止血作用。
Biochem Biophys Res Commun. 2003 Jun 20;306(1):256-60. doi: 10.1016/s0006-291x(03)00943-4.
6
MP4, a new nonvasoactive PEG-Hb conjugate.MP4，一种新型非血管活性聚乙二醇化血红蛋白共轭物。
Transfusion. 2003 Apr;43(4):509-16. doi: 10.1046/j.1537-2995.2003.00341.x.
7
A double-blind study to evaluate the safety of recombinant human hemoglobin in surgical patients during general anesthesia.一项双盲研究，旨在评估重组人血红蛋白在全身麻醉手术患者中的安全性。
J Cardiothorac Vasc Anesth. 2001 Oct;15(5):593-602. doi: 10.1053/jcan.2001.26538.
8
Exchange transfusion with albumin-heme as an artificial O2-infusion into anesthetized rats: physiological responses, O2-delivery, and reduction of the oxidized hemin sites by red blood cells.以白蛋白-血红素进行交换输血作为对麻醉大鼠的人工输氧：生理反应、氧输送以及红细胞对氧化血红素位点的减少作用
Bioconjug Chem. 2000 Jan-Feb;11(1):46-50. doi: 10.1021/bc990065v.
9
Human serum albumin incorporating Tetrakis(o-pivalamido) phenylporphinatoiron(II) derivative as a totally synthetic O2-carrying hemoprotein.结合四（邻新戊酰胺基）苯基卟吩铁（II）衍生物的人血清白蛋白作为一种完全合成的携氧血红蛋白。
Bioconjug Chem. 1999 Sep-Oct;10(5):797-802. doi: 10.1021/bc990019v.
10
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.纤维蛋白原包被的白蛋白微胶囊可减少严重血小板减少兔的出血。
Nat Med. 1999 Jan;5(1):107-11. doi: 10.1038/4795.
Zotero 插件